|Articles|December 10, 2018

FDA Approves Celltrion and Teva’s Biosimilar to Rituxan

FDA has approved Truxima (rituximab-abbs), a biosimilar to Roche’s anti-cancer biologic, Rituxan (rituximab).

Internal server error